Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» metastatic prostate cancer
metastatic prostate cancer
Touting a wad of cash in the wake of a clinical implosion, a small biotech reviews some limited options
Touting a wad of cash in the wake of a clinical implosion, a small biotech reviews some limited options
Endpoints
Tyme Technologies
clinical trials
SM-88
metastatic prostate cancer
Flag link:
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
Pharmaceutical Business Review
NantKwest
clinical trials
t-aNK
metastatic prostate cancer
Flag link:
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
Endpoints
JNJ
Erleada
prostate cancer
metastatic prostate cancer
Flag link:
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
CP Wire
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Flag link:
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Flag link:
Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3
Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3
Fierce Biotech
Halozyme
clinical trials
PEGPH20
metastatic prostate cancer
Flag link:
Battered ArQule shares bump up on badly needed positive data for tivantinib
Battered ArQule shares bump up on badly needed positive data for tivantinib
Fierce Biotech
Arqule
tivantinib
metastatic prostate cancer
Flag link:
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Enzalutamide
prostate cancer
metastatic prostate cancer
Xtandi
Astellas
Flag link:
Jevtana (cabazitaxel) Injection Now Available in the U.S.
Jevtana (cabazitaxel) Injection Now Available in the U.S.
Jevtana
Sanofi
metastatic prostate cancer
Flag link: